rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Steve Dubin

Director

Company insider

Files Form 4 as: Director, Adicet Bio; Chief Executive Officer, Martek Biosciences.

Every Form 4 they filed

In numbers

Trades disclosed
57
Buys
5
Sells
0
Bought
$216K
Sold
$0
Companies
2
Companies where not an officer
1
First trade
11 Sep 2006
Last trade
21 Jun 2026
Last filed
23 Jun 2026

Companies traded

Where they are an officer
Martek BiosciencesDirector, Officer · last 25 Feb 20114 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ACET Adicet BioDirector · Biotechnology · last 21 Jun 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 Jun 2026filed 23 Jun 2026ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—4,200 at $0.00filing
21 Jun 2026filed 23 Jun 2026ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—4,200 at $0.00filing
11 Jun 2025filed 13 Jun 2025ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—26,400 at $0.00filing
11 Jun 2025filed 13 Jun 2025ACET Adicet BioBiotechnologySEC FORM 4 Code A—5,900 at $0.00filing
21 Aug 2024filed 23 Aug 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—30,000 at $0.00filing
21 Aug 2024filed 23 Aug 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
21 Aug 2024filed 23 Aug 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—18,500 at $0.00filing
21 Aug 2024filed 23 Aug 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—18,500 at $0.00filing
21 Aug 2024filed 23 Aug 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—18,500 at $0.00filing
21 Aug 2024filed 23 Aug 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—18,500 at $0.00filing
21 Aug 2024filed 23 Aug 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—26,400 at $0.00filing
21 Aug 2024filed 23 Aug 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—26,400 at $0.00filing
5 Jun 2024filed 7 Jun 2024ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—26,400 at $0.00filing
5 Jun 2024filed 7 Jun 2024ACET Adicet BioBiotechnologySEC FORM 4 Code A—5,900 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—30,000 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—18,500 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—18,500 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code D—18,500 at $0.00filing
14 Aug 2023filed 16 Aug 2023ACET Adicet Biooption or derivative · BiotechnologySEC FORM 4 Code A—18,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.